Johnson & Johnson Innovative Medicine

Pharmaceutical company providing medicines for an array of health concerns in several therapeutic areas. .

Launch date

1953

Employees

Beerse Province of Antwerp (HQ & founding location)

http://www.janssen.com

https://twitter.com/janssenus https://www.linkedin.com/company/janssen-pharmaceutical-companies-of-johnson-and-johnson

Date	Investors	Amount	Round
-	Nordic Biotech	N/A	-
Jun 2009	Polaris Partners Flybridge Capital Partners Flagship Pioneering	$15.0m	Series A
Dec 2009	Flybridge Capital Partners	$5.0m	Series A
Jul 2010	Flybridge Capital Partners	$1.2m	Early VC
Apr 2011	Polaris Partners Third Rock Ventures Flybridge Capital Partners Flagship Pioneering	$18.4m	Series B
Mar 2013	Polaris Partners Third Rock Ventures Flybridge Capital Partners Flagship Pioneering	$13.5m	Early VC
Oct 2015	Polaris Partners Flagship Pioneering RA Capital Management	$32.0m	Late VC
Jun 2016	Yonjin Venture	N/A	Series A
Jan 2017	RA Capital Management	N/A	Seed
Dec 2017	Polaris Partners Bristol-Myers Squibb Flagship Pioneering RA Capital Management Millhouse Yonghua Capital	$25.0m	Series B
Feb 2020	ASPR	$456m	Grant
Feb 2020	ASPR	$152m	Grant
Mar 2020*	Johnson & Johnson ASPR	$1.0b	Grant
Aug 2020	ASPR	$1.0b	Grant
Total Funding		€2.5b

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Johnson & Johnson Innovative Medicine Mar 2015

ACQUISITION by Johnson & Johnson Innovative Medicine Jul 2012

Vertex Pharmaceuticals

exited

Quanticare Technologies